12th EDRN Scientific Workshop - Tuesday 23 March Agenda

20th Year of EDRN: Making Cancer Detection Possible

Tuesday, March 23, 2021 (9:45 a.m. - 6:10 p.m. Eastern Daylight Time)

9:45 a.m. - 9:50 a.m. EDT
(all times Eastern Daylight Time)

Admittance to Workshop via Zoom/General Announcements

9:50 a.m. - 10:05 a.m. EDT

Welcome and Opening of the March 2021 EDRN Scientific Workshop

  • Joshua LaBaer, MD, PhD, Arizona State University/The Biodesign Institute
  • Arul Chinnaiyan, MD, PhD, University of Michigan
  • Sudhir Srivastava, PhD, MPH, National Cancer Institute
10:05 a.m. - 10:15 a.m. EDT

Opening Remarks

  • Ned Sharpless, MD, Director, National Cancer Institute
10:15 a.m. - 10:45 a.m. EDT

01: Life-Time Experience with Cancer Diagnostics

  • Robert Bast, MD, The University of Texas MD Anderson Cancer Center
10:45 a.m. - 1:15 p.m. EDT

Session 1 - Integrated Approaches to Biomarker Research

10:45 a.m. - 10:50 p.m. EDT

Introduction to the Session

Moderators:
  • Denise Aberle, MD, University of California, Los Angeles
  • Hui Zhang, PhD, Johns Hopkins University School of Medicine
10:50 a.m. - 11:10 a.m. EDT

02: Precision Medicine of Lung Cancer: Metabolome and Microbiome

  • Curt Harris, MD, National Cancer Institute
11:10 a.m. - 11:15 a.m. EDT

Q&A

11:15 a.m. - 11:35 a.m. EDT

03: Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors

  • Arul Chinnaiyan, MD, PhD, University of Michigan
11:35 a.m. - 11:40 a.m. EDT

Q&A

11:40 a.m. - 11:50 a.m. EDT

Break

11:50 a.m. - 12:10 p.m. EDT

04: DNA Methylation Detection for Early Lung Cancer Specificity and Universal Cancer Detection using Plasma

  • James Herman, MD, University of Pittsburgh School of Medicine
12:10 p.m. - 12:15 p.m. EDT

Q&A

12:15 p.m. - 12:35 p.m. EDT

05: The Immunogenicity of Post-Translational Protein Modifications

  • Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute
12:35 p.m. - 12:40 p.m. EDT

Q&A

12:40 p.m. - 1:10 p.m. EDT

06: Toward noninvasive early cancer detection using circulating DNA

  • Ash Alizadeh, MD, PhD, Stanford Comprehensive Cancer Center
1:10 p.m. - 1:15 p.m. EDT

Q&A

1:15 p.m. - 1:35 p.m. EDT

Break

1:35 p.m. - 3:45 p.m. EDT

Session 2 - Integrated Approaches to Biomarker Research II

1:35 p.m. - 1:40 p.m. EDT

Introduction to the Session

Moderators:
  • Surinder Batra, PhD, University of Nebraska Medical Center
  • Zhen Zhang, PhD, Johns Hopkins University School of Medicine
1:40 p.m. - 2:00 p.m. EDT

07: Decoding the Cancer Mucinome

  • Carolyn Bertozzi, PhD, Stanford School of Humanities and Sciences
2:00 p.m. - 2:05 p.m. EDT

Q&A

2:05 p.m. - 2:25 p.m. EDT

08: Moffitt Imaging Biomarker VAlidation Center (MIBVAC)

  • Matthew Schabath, PhD, H. Lee Moffit Cancer Center and Research Institute
2:25 p.m. - 2:30 p.m. EDT

Q&A

2:30 p.m. - 2:50 p.m. EDT

09: Multi-Disciplinary Strategies for Cancer Early Detection

  • Victoria Seewaldt, MD, City of Hope
2:50 p.m. - 2:55 p.m. EDT

Q&A

2:55 p.m. - 3:15 p.m. EDT

10: Integrated approach towards pancreatic cancer biomarker development

  • Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center
3:15 p.m. - 3:20 p.m. EDT

Q&A

3:20 p.m. - 3:40 p.m. EDT

11: A Unique Approach Combining Avatar Mice and Mass Spectrometry to Identify Blood Biomarkers for Early Detection of Breast Cancer

  • Amanda Paulovich, MD, PhD, Fred Hutchinson Cancer Research Center
3:40 p.m. - 3:45 p.m. EDT

Q&A

3:45 p.m. - 4:00 p.m. EDT

Break

4:00 p.m. - 6:10 p.m. EDT

Session 3 - Research Excellence through Alliance of Consortia

4:00 p.m. - 4:05 p.m. EDT

Introduction to the Session

Moderator:

  • Barbara Kenner, PhD, Kenner Family Research Fund
4:05 p.m. - 4:25 p.m. EDT

12: Using markers to improve pancreatic cancer screening and surveillance

  • Michael Goggins, MD, Johns Hopkins University School of Medicine
4:25 p.m. - 4:30 p.m. EDT

Q&A

4:30 p.m. - 4:50 p.m. EDT

13: Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer

  • Stephen Pandol, MD, Cedars-Sinai Medical Center
4:50 p.m. - 4:55 p.m. EDT

Q&A

4:55 p.m. - 5:15 p.m. EDT

14: Translational Liver Consortium

  • Hashem El-Serag, MD, MPH, Baylor College of Medicine
5:15 p.m. - 5:20 p.m. EDT

Q&A

5:20 p.m. - 5:40 p.m. EDT

15: Exosomes - Rigor and Reproducibility

  • David Lyden, MD, PhD, Weill Cornell Medical College
5:40 p.m. - 5:45 p.m. EDT

Q&A

5:45 p.m. - 6:05 p.m. EDT

16: Pre-Cancer Atlas

  • Peter Sorger, PhD, Harvard Medical School
6:05 p.m. - 6:10 p.m. EDT

Q&A

6:10 p.m. EDT

Adjourn for the Day

Version 5.1.0